気管支喘息治療薬ツロブテロールの経皮吸収型製剤の開発
スポンサーリンク
概要
- 論文の詳細を見る
β_2-Adrenergic agonists have been widely used to treat patients with asthma. Usually, oral dosage forms of β_2-agonists have been used, but side effects such as palpitation and tremor have been reported because of excessive serum levels around Tmax. It is said that circadian variations exist in the manifestation of asthma with maximum incidence of asthma attacks in early morning at around 4 a.m., the so-called morning dip. Chronotherapy for asthma based on circadian rhythm should be more efficient and have a lower frequency of side effects. Accordingly we developed a transdermal delivery system or the β_2-agonist tulobuterol adapted to the circadian rhythm. The system is designed to administer the appropriate dose or the drug at an optimal time using the so-called Crystal Reservoir System. The superiority or the transdermal formulation of tulobuterol over the current therapy using oral formulations of β_2-stimulants was indicated by its excellent pharmacokinetic profile, and confirmed by the results of clinical trials. This formulation is the first transdermal chrono-delivery system reported anywhere in the world, and is expected to provide more effective and safe treatment or asthma and related diseases not only in adults, but also especially in children.
- 社団法人日本薬学会の論文
- 2002-01-01
著者
-
加藤 日出男
北陸製薬株式会社
-
永田 治
北陸製薬株式会社
-
山崎 昌弘
北陸製薬株式会社
-
鈴木 利広
北陸製薬株式会社
-
仲野 善久
日東電工株式会社
-
仲野 善久
日東電工
-
仲野 善久
日東電工株式会社 メディカル事業部 研究開発センター
-
加藤 日出男
北陸製薬株式会社中央研究所
-
永田 治
北陸製薬株式会社 研究開発本部
関連論文
- 気管支喘息治療薬ツロブテロールの経皮吸収型製剤の開発
- 232 新規TXA_2/LTD_4デュアル拮抗薬RS-601の抗喘息作用
- Benzenesulfonamide誘導体の合成とThromboxane A_2及びLeukotriene D_4に対するDual拮抗作用
- Amphoteric Drugs. II. Synthesis and Antiallergic Activity of [4-(5H-Dibenzo[a, d]cycloheptan-5-ylidene)piperidino]alkanoic Acid Derivatives and Related Compounds
- Amphoteric Drugs. I. Synthesis and Antiallergic Activity of [4-(Diphenylmethoxy)piperidino]-, [4-(Diphenylmethyl)piperazinyl]-and [4-(Diphenylmethylene)piperidino]alkanoic Acid Derivatives
- Transport Mechanism of an H_1-Antagonist at the Blood-Brain Barrier : Transport Mechanism of Mepyramine Using the Carotid Injection Technique
- 医薬品の両性イオン化(第3報)1,2,3,4,10,14b-Hexahydrodibenzo-[c, f]pyrazino[1,2-α]azepine及び2,3,4,9-Tetrahydro-1H-dibenzo[3,4 : 6,7]cyclohepta[1,2-c]pyridineのN-Alkylcarboxylic Acid誘導体の合成とその薬理作用
- Study on Zwitter-Ionization of Drugs. II. Synthesis and Pharmacological Activity of Some N-[3-(5H-Dibenzo[a, d]cyclohepten-5-ylidene)propyl]-N-methylamino- and N-[3-(6H-Dibenz[b, e]oxepin-11-ylidene)propyl]-N-methylamino-alkanoic Acid Derivatives and Rela
- INTER-INDIVIDUAL DIFFERENCES OF (+)-4-[4-(4-METHYLPHENYL)PHENYLMETHOXY-1-PIPERIDINYL]BUTYRIC ACID ((+)-MPPB) DISPOSITION IN RATS
- 医薬品の両性イオン化(第1報)4-(2-Chlorodibenz[b, f][1,4]oxazepin-11-yl)piaerazine, 4-(2-Chlorodibenzo[b, f][1,4]thiazepin-11-yl)-piperazine及び4-(11H-Dibenz[b, e]azepin-6-yl)piperazineのN-アルキルカルボン酸誘導体の合成とその薬理作用
- Novel Phenoxyalkylamine Derivatives. VII. Synthesis and Pharmacological Activities of 2-Alkoxy-5-[(Phenoxyalkylamino)alkyl]benzenesulfonamide Derivatives
- Synthesis, Gastrointestinal Prokinetic Activity and Structure-Activity Relationships of Novel N-[[2-(Dialkylamino)ethoxy)benzyl]benzamide Derivatives
- Quinolone系抗菌剤の研究(第3報)5-Amino-7-(2-aminoalkoxy)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid及びその関連化合物の合成と抗菌活性
- Ouinolone系抗菌剤の研究(第2報)7-Aminoalkoxy-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid及びその関連化合物の合成と抗菌活性
- 新規なPhenoxyalkylamine誘導体(第6報)α-[(Phenoxyethylamino)propyl]-α-phenylacetonitrile誘導体の合成とα-遮断作用
- Studies on Antiallergic Agents. II. : Quantitative Structure-Activity Relationships of Novel 6-Substituted N-(1H-Tetrazol-5-yl)-2-pyrazinecarboxamides
- Quinolone系抗菌剤の研究(第1報)7-(2-Aminoethoxy)-, 7-(2-Aminoethylthio)-及び7-(2-Aminoethylamino)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid及びそれらの誘導体の合成と抗菌活性
- Studies on Antiallergic Agents. I. : Synthesis and Antiallergic Activity of Novel Pyrazine Derivatives
- Novel Phenoxyalkylamine Derivatives. V. : Synthesis, α-Blocking Activity and Quantitative Structure-Activity Analysis of α-[(Phenoxyethylamino)propyl]-α-phenylacetonitrile Derivatives
- Novel Phenoxyalkylamine Derivatives. IV. : Synthesis, Ca^-Antagonistic Activity and Quantitative Structure-Activity Analysis of α-Isopropyl-α-[3[3-(3-methoxyphenoxy)propylamino]propyl]-α-phenylacetonitrile Derivatives
- Synthesis and Histamine H_2-Antagonist Activity of 4-Quinazolinone Derivatives
- Novel Phenoxyalkylamine Derivatives. III. : Quantitative Structure-Activity Relationships of Ca^-Antagonistic α-Alkyla-α-[(phenoxypropylamino)propyl]-3,4,5-trimethoxy-benzeneacetonitrile Derivatives
- Novel Phenoxyalkylamine Derivatives. II. : Synthesis and Ca^-Antagonistic Activities of α-Alkyl-α-[(phenoxypropylamino)propyl]-benzeneacetonitrile Derivatives
- Novel Phenoxyalkylamine Derivatives. I. : Synthesis and Pharmacological Activities of α-Isopropyl-α-[(phenoxyalkylamino)alkyl]-benzeneacetonitrile Derivatives
- (2-Pyrimidinylamino)phenylacetic Acid誘導体の合成と抗炎症作用
- Dexamethasone valerate (DV-17) と他の副腎皮質ステロイド外用剤のラット比較毒性試験
- Dexamethasone valerate (DV-17)と他の副腎皮質ステロイド外用剤のウサギにおける刺激性試験 : 皮膚および眼粘膜一次刺激性試験ならびに皮膚累積刺激性試験
- Study on Zwitter-Ionization of Drugs. II. Synthesis and Pharmacological Activity of Some N-[3-(5H-Dibenzo[a, d]cyclohepten-5-ylidene)propyl]-N-methylamino- and N-[3-(6H-Dibenz[b, e]oxepin-11-ylidene)propyl]-N-methylamino-alkanoic Acid Derivatives and Rela
- Study on Zwitter-Ionization of Drugs. II. Synthesis and Pharmacological Activity of Some N-[3-(5H-Dibenzo[a, d]cyclohepten-5-ylidene)propyl]-N-methylamino- and N-[3-(6H-Dibenz[b, e]oxepin-11-ylidene)propyl]-N-methylamino-alkanoic Acid Derivatives and Rela
- Study on Zwitter-Ionization of Drugs. II. Synthesis and Pharmacological Activity of Some N-[3-(5H-Dibenzo[a, d]cyclohepten-5-ylidene)propyl]-N-methylamino- and N-[3-(6H-Dibenz[b, e]oxepin-11-ylidene)propyl]-N-methylamino-alkanoic Acid Derivatives and Rela
- Study on Zwitter-Ionization of Drugs. II. Synthesis and Pharmacological Activity of Some N-[3-(5H-Dibenzo[a, d]cyclohepten-5-ylidene)propyl]-N-methylamino- and N-[3-(6H-Dibenz[b, e]oxepin-11-ylidene)propyl]-N-methylamino-alkanoic Acid Derivatives and Rela
- Study on Zwitter-Ionization of Drugs. II. Synthesis and Pharmacological Activity of Some N-[3-(5H-Dibenzo[a, d]cyclohepten-5-ylidene)propyl]-N-methylamino- and N-[3-(6H-Dibenz[b, e]oxepin-11-ylidene)propyl]-N-methylamino-alkanoic Acid Derivatives and Rela
- Study on Zwitter-Ionization of Drugs. II. Synthesis and Pharmacological Activity of Some N-[3-(5H-Dibenzo[a, d]cyclohepten-5-ylidene)propyl]-N-methylamino- and N-[3-(6H-Dibenz[b, e]oxepin-11-ylidene)propyl]-N-methylamino-alkanoic Acid Derivatives and Rela
- Study on Zwitter-Ionization of Drugs. II. Synthesis and Pharmacological Activity of Some N-[3-(5H-Dibenzo[a, d]cyclohepten-5-ylidene)propyl]-N-methylamino- and N-[3-(6H-Dibenz[b, e]oxepin-11-ylidene)propyl]-N-methylamino-alkanoic Acid Derivatives and Rela
- Crystal Structures of Polymorphs of α-[(tert-Butylamino) methyl]-2-chloro-4-hydroxybenzyl Alcohol Hydrochloride (HOKU-81)
- 鎮痙剤の研究(第7報)N-Alkyl Diarylmethylenequinolizidinium Bromides, N-Alkyl Diarylmethyleneindolizidinium Bromidesおよび関連化合物の構造活性相関
- 鎮痙薬の薬理学的研究(第1報)Diarylmethylene-5-methyl-transquinolizidinium Bromide類の鎮痙作用への選択性
- Studies on Antispasmodics. VI. Synthesis of N-Alkyl 6- and 7-Diarylmethyleneindolizidinium Bromides
- Studies on Antispasmodics. V. Synthesis and Anticholinergic Activity of N-Alkyl 1- and 2-Diarylmethylene-indolizidinium Bromides
- 鎮痙剤の研究(第4報)Diarylhydroxymethylquinolizidine Methohalidesの合成と抗アセチルコリン作用
- 鎮痙剤の研究(第3報)2位置換Quinolizidine類の簡便な新合成法とそれらの立体構造について
- 鎮痙剤の研究(第2報)3位置換Quinolizidine類の簡便な新合成法とそれらの立体構造について
- Studies on Antispasmodics. I. Synthesis and Anticholinergic Activity of 1-, 2-, and 3-Diarylmethylenequinolizidine Quaternary Ammonium Salts
- o-Chloro-α-(tert-butylaminomethyl)benzylalcohol Hydrochloride(C-78)および関連化合物の合成と気管支拡張作用
- Studies on 1-Azabicyclo Compounds. XXVI. Synthesis of Ten-membered Ring Amines from 9a-Cyanomethyl-, 9a-Ethoxycarbonylmethyl-, and 1-Ethoxycarbonyl-octahydroquinolizine
- Studies on the Relationship between Physico-chemical Properties and Crystalline Forms of Tulobuterol Hydrochloride. II. Crystal Structure Analyses of the Four Crystalline Forms of Tulobuterol Hydrochloride
- 2-Methyl-3-pyrrolidinopropiophenone誘導体の中枢性筋弛緩作用
- Tulobuterolの生体内運命(第5報)ラット, イヌ, モルモットおよびウサギにおける代謝および排泄に関する種差
- ツロブテロールの生体内運命(第4報)ラット日齢と生体内動態について
- 塩酸ツロブテールの性状と結晶形との相関に関する研究(第3報) : 塩酸ツロブテール多形の吸湿特性
- 塩酸ツロブテロールの性状と結晶形との相関に関する研究(第3報)塩酸ツロブテロール多形の吸湿特性
- Studies on the Relationship between Physico-chemical Properties and Crystalline Forms of Tulobuterol Hydrochloride. I. Polymorphism of Tulobuterol Hydrochloride
- ツロブテロールテープ剤の体内動態 (第3報) : 幼若ラットにおける単回貼付後の吸収, 分布および排泄
- ツロブテロールテープ剤の体内動態 (第2報) : ラットにおける反復貼付後の吸収, 分布および排泄
- ツロブテロールテープ剤の体内動態 (第1報) : ラットにおける単回貼付後の吸収, 分布, 代謝および排泄
- 塩酸イトプリドのラットにおける胃筋層への分布 - ラジオルミノグラフィーによる定量的解析 -
- 胃粘膜微小循環に及ぼす3-(Di-2-thienylmethylene)-5-methyl-trans-quinolizidinium Bromide(HSR-902)の影響
- 経皮吸収型医薬品
- Polymorphism of α-[(tert-Butylamino) methyl]-2-chloro-4-hydroxybenzyl Alcohol Hydrochloride (HOKU-81)
- 1-Azabicyclo化合物の研究(第21報)1,2,3,10,11,11a-Hexahydro-5H-pyrrolo-[2,1-c][1,4]benzodiazepin-11-oneおよび5,6,6a, 7,8,9,10,12-Octahydropyrido[2,1-c][1,4]benzodiazepin-6-oneから中環状AminolactamおよびSpiroaminolactam体の合成
- Studies on 1-Azabicyclo Compounds. XVI. Synthesis of 1'-Methylindan-2-spiro-2'-piperazine and Related Compounds
- Studies on 1-Azabicyclo Compounds. XV. Oxidation of 1,3,4,6,11,11a-Hexahydro-2H-pyrazino [1,2-b] isoquinolin-1-one Derivatives with Mercuric Acetate, and Their Conversion into 1,2,3,4,5,6,7,8-Octahydro-2-methyl-2,5-benzodiazecine and Related Compounds
- 1-Azabicyclo化合物の研究その5 : 4-Oxoquinolizidineの水素化リチウムアルミニウム還元およびQuinolizidineの酢酸第二水銀酸化により得られた二量体の化学構造
- Diazabicycloalkanesの研究(第2報)4-[β-(10-Phenothiazinyl)-ethyl]-1,4-diazabicyclo[4,4,0]-decaneおよび類似化合物の抗ヒスタミン作用ならびに向精神作用
- 経皮吸収型貼付製剤用粘着剤の要求特性
- 臭化チキジウム
- 鎮痙薬の薬理学的研究(第5報) : 3-(Di-2-Thienylmethylene)-5-Methyl-trans-Quinolizidinium Bromide (HSR-902) の骨盤神経終末と膀胱壁筋との神経伝達に及ぼす作用
- 鎮痙薬の薬理学的研究(第3報) 3-(Di-2-Thienylmethylene)-5-Methyl-trans-QuinolizidiniumBromide(HSR-902)の鎮痙作用とその臓器特異性
- 3-(5-Nitro-2-furyl)-benzo-1,2,4-triazine誘導体の合成ならびに抗細菌作用について
- 1-Azabicyclo化合物の研究(第20報)Hexahydroisoquino[3,2-c][1,4]benzodiazepineおよび関連化合物の合成ならびにHexahydroisoquino[3,2-c]-[1,4]benzodiazepin-13-one から6-Methyl-hexahydro-5H-dibenzo[b, g][1,5]diazacycloundecineの生成
- 1-Azabicyclo化合物の研究(第25報)Octahydropyrrolo[1,2-α]pyrazin-1-oneから9員環状Aminolactamおよび関連化合物の合成